Medicare Enrolled
Joseph Nezgoda, M. D.
Ophthalmology · West Palm Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Nezgoda from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Nezgoda?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Nezgoda
Joseph Nezgoda is an ophthalmology specialist in West Palm Beach, FL, with 17 years of NPI registration. Based on federal Medicare data, Nezgoda performed 17,931 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Nezgoda received a total of $570,286 from 51 pharmaceutical and/or device companies across 695 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Nezgoda is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 8% volume in FL
$570,286 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗17,931
Medicare services
Top 8% in FL for ophthalmology
Not available
Unique patients (not deduplicated)
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
6,121 | $29 | $75 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
2,333 | $31 | $72 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
2,267 | $97 | $197 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
1,430 | $93 | $369 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
1,139 | $35 | $189 |
| Compounded drug, not otherwise classified A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products. |
1,111 | $66 | $222 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
1,021 | $1 | $49 |
| Injection, ranibizumab, 0.1 mg | 792 | $177 | $468 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
393 | $19 | $60 |
| Injection into eye membrane A procedure involving the injection of a drug or substance into the membrane that covers the eyeball. |
304 | $42 | $232 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
203 | $29 | $119 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
143 | $70 | $109 |
| Fluorescein angiography of retina A special camera captures images of the blood vessels in the retina and the area between the white part of the eye and the retina after a dye is injected. |
135 | $201 | $784 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
104 | $106 | $177 |
| Visual field test, intermediate A test that measures your side vision to check for blind spots or other vision changes. |
103 | $36 | $143 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
78 | $547 | $1,626 |
| Tear duct plug insertion A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface. |
75 | $80 | $201 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
42 | $110 | $220 |
| Retinal laser destruction of growth A laser procedure used to destroy abnormal growths in the retina. |
39 | $403 | $1,587 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $135 | $349 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
23 | $48 | $117 |
| Eye photography Photographic imaging of the interior structures of the eye. |
23 | $19 | $59 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
14 | $22 | $86 |
| Laser destruction of vitreous and retina A laser procedure used to destroy fluid in the vitreous and tissue across the entire retina. |
12 | $787 | $3,495 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$570,286
Total received (2018-2024)
Avg $81,469/year across 7 years
Top 1% in FL for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
695
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$109,400
2023
$67,671
2022
$109,054
2021
$25,900
2020
$35,549
2019
$170,710
2018
$52,001
Payments by company (2024)
Genentech USA, Inc.
$51,867
Apellis Pharmaceuticals, Inc.
$47,486
ANI Pharmaceuticals, Inc.
$7,993
Alimera Sciences, Inc.
$390
Harrow Eye, LLC
$360
NEW WORLD MEDICAL,INC.
$278
ABBVIE INC.
$256
Mallinckrodt Hospital Products Inc.
$186
Tarsus Pharmaceuticals, Inc.
$150
Astellas Pharma US Inc
$149
Rayner Intraocular Lenses Limited
$125
Alcon Vision LLC
$70
Dompe US, Inc.
$39
Regeneron Healthcare Solutions, Inc.
$33
Johnson & Johnson Surgical Vision, Inc.
$20
Top 3 companies account for 98.1% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$337,906
Novartis Pharmaceuticals Corporation
$108,335
Apellis Pharmaceuticals, Inc.
$47,799
Mallinckrodt Hospital Products Inc.
$27,067
Dutch Ophthalmic, USA
$10,209
Allergan Inc.
$9,036
ANI Pharmaceuticals, Inc.
$8,067
Mallinckrodt Enterprises LLC
$5,095
Alimera Sciences, Inc.
$2,227
EyePoint Pharmaceuticals US, Inc.
$2,056
ABBVIE INC.
$1,545
Allergan, Inc.
$1,196
Bausch & Lomb, a division of Bausch Health US, LLC
$974
Horizon Therapeutics plc
$696
Regeneron Healthcare Solutions, Inc.
$625
Kala Pharmaceuticals, Inc.
$533
Sun Pharmaceutical Industries Inc.
$515
Johnson & Johnson Surgical Vision, Inc.
$502
TOPCON MEDICAL SYSTEMS, INC.
$365
Harrow Eye, LLC
$360
NEW WORLD MEDICAL,INC.
$341
Aerie Pharmaceuticals, Inc.
$334
Astellas Pharma US Inc
$326
Glaukos Corporation
$280
Rayner Intraocular Lenses Limited
$258
Ocular Therapeutix, Inc.
$254
EYEVANCE PHARMACEUTICALS LLC
$244
Coherus Biosciences Inc.
$239
Omeros Corporation
$234
SUN PHARMACEUTICAL INDUSTRIES INC.
$227
Alcon Vision LLC
$214
Sight Sciences, Inc.
$212
Heidelberg Engineering, Inc.
$208
Carl Zeiss Meditec USA, Inc.
$201
Bausch & Lomb Americas Inc.
$186
Tarsus Pharmaceuticals, Inc.
$150
Abbott Laboratories
$145
Dompe US, Inc.
$141
OPTOVUE, INC.
$135
TISSUETECH, INC.
$135
TissueTech, Inc.
$124
Eyevance Pharmaceuticals LLC
$107
Spark Therapeutics, Inc.
$106
Ivantis, Inc
$99
Oyster Point Pharma, Inc.
$98
Carl Zeiss Meditec, Inc.
$58
NOVARTIS PHARMACEUTICALS CORPORATION
$45
Mallinckrodt LLC
$24
Alcon Laboratories Inc
$20
Genentech, Inc.
$18
Shire North American Group Inc
$18
Top 3 companies account for 86.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVEFOCUS · AcrySof IQ PanOptix · Ahmed Glaucoma Valve · BEOVU · BROMSITE · CEQUA · Cequa · Cimerli · Constellation · DEXTENZA · DEXYCU · DURYSTA · ENVISTA · EVA · EVA Ophthalmic Surgical System · EYLEA · EYLEA HD · EYSUVIS · Flarex · Hydrus · IHEEZO · ILUVIEN · INFUSE · INVELTYS · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · Iluvien · Izervay · Kahook Dual Blade · LOTEMAX · LOTEMAX GEL · LOTEMAX SM · LUMIGAN · LUXTURNA · Lucentis · Non-Covered Product · OCT · OCT TRITON · OCT-TRITON · OMIDRIA · OMNI · OPMI Lumera · OXERVATE · OZURDEX · Omidria · PROLENSA · PURIFIED CORTROPHIN GEL · Prokera · QUATERA 700 · RETISERT · RayOne EMV · Rhopressa · STELLARIS PC · SUSVIMO · Spectralis · Supera peripheral stent system · Syfovre · TEPEZZA · TYRVAYA · TearCare · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · Tecnis Simplicity · TobraDex ST · VABYSMO · VYZULTA · Vabysmo · XDEMVY · XELPROS · XIIDRA · YUTIQ · combined machine · iStent Trabecular Micro-Bypass Stent System · rhopressa
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Ophthalmologists in nearby ZIP areas
130
County median income
$81,115
Nearest hospital to ZIP centroid (approximate)
GOOD SAMARITAN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Nezgoda is a mixed practice specialist, with above-average Medicare volume (top 8% in FL), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Nezgoda experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Nezgoda performed 6,121 eye injection (vabysmo/faricimab) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Nezgoda receive payments from pharmaceutical companies?
Yes. Nezgoda received a total of $570,286 from 51 companies across 695 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Nezgoda's costs compare to other ophthalmologists in West Palm Beach?
Nezgoda's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Nezgoda) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in West Palm Beach
Browse ophthalmologists in West Palm Beach ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in FL
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in FL
Which FL ophthalmologists receive the most from drug and device companies.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Apellis Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Apellis Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology